Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Two-color SERS microscopy for protein co-localization in prostate tissue with primary antibody-protein A/G-gold nanocluster conjugates.

Salehi M, Schneider L, Ströbel P, Marx A, Packeisen J, Schlücker S.

Nanoscale. 2014 Feb 21;6(4):2361-7. doi: 10.1039/c3nr05890e. Epub 2014 Jan 16.

PMID:
24430775
2.

Rapid immuno-SERS microscopy for tissue imaging with single-nanoparticle sensitivity.

Salehi M, Steinigeweg D, Ströbel P, Marx A, Packeisen J, Schlücker S.

J Biophotonics. 2013 Oct;6(10):785-92. doi: 10.1002/jbio.201200148. Epub 2012 Dec 7.

PMID:
23225645
3.

Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes.

Liedtke C, Packeisen J, Hess KR, Vogt U, Kiesel L, Kersting C, Korsching E, Brandt B, Buerger H.

Eur J Cancer. 2012 Sep;48(13):2066-74. doi: 10.1016/j.ejca.2011.08.006. Epub 2011 Sep 13.

PMID:
21920731
4.

Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women.

Stute P, Szuwart T, Schlueter M, Götte M, Packeisen J, Kiesel L.

Maturitas. 2008 Feb 20;59(2):163-73. doi: 10.1016/j.maturitas.2007.12.005. Epub 2008 Feb 8.

PMID:
18261865
5.
6.

Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.

Kersting C, Packeisen J, Leidinger B, Brandt B, von Wasielewski R, Winkelmann W, van Diest PJ, Gosheger G, Buerger H.

J Clin Pathol. 2006 Jun;59(6):585-90. Epub 2006 Feb 3.

7.

Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity.

Fillies T, Werkmeister R, Packeisen J, Brandt B, Morin P, Weingart D, Joos U, Buerger H.

BMC Cancer. 2006 Jan 13;6:10.

8.

Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility.

Brandt B, Kemming D, Packeisen J, Simon R, Helms M, Feldmann U, Matuschek A, Kersting C, Hinrichs B, Bidart JM, Bellet D, Bartkowiak K, Dankbar N, Dittmar T, Sauter G, Boecker W, Buerger H.

Endocr Relat Cancer. 2005 Dec;12(4):823-37.

9.

Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression.

Kersting C, Kuijper A, Schmidt H, Packeisen J, Liedtke C, Tidow N, Gustmann C, Hinrichs B, Wülfing P, Tio J, Boecker W, van Diest P, Brandt B, Buerger H.

Lab Invest. 2006 Jan;86(1):54-61.

10.

Cytogenetic differences in breast cancer samples between German and Japanese patients.

Packeisen J, Nakachi K, Boecker W, Brandt B, Buerger H.

J Clin Pathol. 2005 Oct;58(10):1101-3.

11.

The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?

Korsching E, Packeisen J, Liedtke C, Hungermann D, Wülfing P, van Diest PJ, Brandt B, Boecker W, Buerger H.

J Pathol. 2005 Aug;206(4):451-7.

PMID:
15906273
12.

First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.

Helms MW, Packeisen J, August C, Schittek B, Boecker W, Brandt BH, Buerger H.

J Pathol. 2005 Jul;206(3):366-76.

PMID:
15892165
13.

Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.

Buerger H, Packeisen J, Boecker A, Tidow N, Kersting C, Bielawski K, Isola J, Yatabe Y, Nakachi K, Boecker W, Brandt B.

J Pathol. 2004 May;203(1):545-50.

PMID:
15095477
14.

Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry.

Korsching E, Packeisen J, Helms MW, Kersting C, Voss R, van Diest PJ, Brandt B, van der Wall E, Boecker W, Bürger H.

Br J Cancer. 2004 Apr 5;90(7):1422-8.

15.

Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia.

Müller-Tidow C, Metzelder SK, Buerger H, Packeisen J, Ganser A, Heil G, Kügler K, Adigüzel G, Schwäble J, Steffen B, Ludwig WD, Heinecke A, Büchner T, Berdel WE, Serve H.

Leukemia. 2004 Apr;18(4):720-6.

PMID:
14973498
16.

Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

Raaphorst FM, Meijer CJ, Fieret E, Blokzijl T, Mommers E, Buerger H, Packeisen J, Sewalt RA, Otte AP, van Diest PJ.

Neoplasia. 2003 Nov-Dec;5(6):481-8.

17.

High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade.

Flohr AM, Rogalla P, Bonk U, Puettmann B, Buerger H, Gohla G, Packeisen J, Wosniok W, Loeschke S, Bullerdiek J.

Histol Histopathol. 2003 Oct;18(4):999-1004. doi: 10.14670/HH-18.999.

PMID:
12973668
18.

Demystified...tissue microarray technology.

Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H.

Mol Pathol. 2003 Aug;56(4):198-204. Review.

19.

Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.

Korsching E, Packeisen J, Agelopoulos K, Eisenacher M, Voss R, Isola J, van Diest PJ, Brandt B, Boecker W, Buerger H.

Lab Invest. 2002 Nov;82(11):1525-33.

PMID:
12429812
20.

Tissue microarrays: a new approach for quality control in immunohistochemistry.

Packeisen J, Buerger H, Krech R, Boecker W.

J Clin Pathol. 2002 Aug;55(8):613-5.

Supplemental Content

Loading ...
Support Center